|
Market Cap (5-Jun) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
PAA released this announcement to the ASX on 4 January 2021, 8:16. The announcement is not marked as price sensitive, and is 16 page(s) in length and 502.57kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.052% short sold according to ASIC data. It was ranked the 453rd most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Appendix 2A & s708 notice | 4 January 2021, 8:16 |
| PAA Commences Manufacture of GMP-Grade MPL for Human Trials | 23 December 2020, 8:21 |
| PharmAust to Commence Phase IIb Dog Cancer Trial | 22 December 2020, 8:15 |
| Epichem Awarded Contract Extension from DNDi | 21 December 2020, 8:18 |
You must be logged in to post a reply.
PharmAust 